Shoppers Drug Mart reports EVP, CFO Halatsis’ resignation
TORONTO Shoppers Drug Mart last week announced that George Halatsis, EVP and CFO, will be leaving the company later this month to pursue another career opportunity.
Bradley Lukow will succeed Halatsis, the company stated.
“[Halatsis] has made a very solid contribution to our success at Shoppers Drug Mart over the past six years,” said Jurgen Schreiber, Shoppers president and CEO. “Although we are sorry to see him leave, our strong succession plan in finance ensures we will have a smooth transition and continued strong leadership with [Lukow] as our CFO.”
Lukow’s experience with Shoppers Drug Mart spans over 14 years in senior finance roles with the company, as well as prior experience in the grocery retail industry. He joined Shoppers Drug Mart in 1994, and held roles of increasing responsibility in the finance department.
Assurant Health announces benefits partnership with Take Care
MILWAUKEE Assurant Health has announced that its health plan members can now receive in-network benefits at all Take Care Clinics.
With the addition of the 322 Take Care Clinics, which are located within Walgreens stores, Assurant Health customers with Individual Medical, Short Term Medical and Real Choices Small Group plans have access to more than 800 retail health clinics throughout the United States.
“This agreement is part of our continuing commitment to give our customers more choices and convenient access to affordable health care options,” said Scott Krienke, SVP of product lines for Assurant Health.
Added Peter Miller, president and CEO of Take Care Health Systems, “Our goal is to provide access to care to as many individuals as possible. Partnering with companies like Assurant Health allows us to offer our model of care to more individuals across the country, and this national contract sets the stage for continued coverage as we expand our model to new markets and states.”
FDA approves generic version of Medicis’ Loprox
ROCKVILLE, Md. The Food and Drug Administration has approved a generic version of Medicis’ Loprox, FDA records show.
The agency approved Paddock’s ciclopirox gel in the 0.77 percent strength on Jan. 7. The gel is used to treat seborrheic dermatitis.
Medicis’ non-acne skin medicines had sales of $173 million in 2007, according to Medicis financial data, which did not list separate figures for Loprox. Nycomed also makes a generic version of the 0.77 formulation, while Medicis continues to market the 1 percent formulation.